TMCnet News
Stock to Watch: Cardiome Pharma Up 5.6% (CRME)Feb 04, 2013 (SmarTrend(R) Spotlight via COMTEX) -- Cardiome Pharma (NASDAQ:CRME) is one of today's best performing penny stocks, up 5.6% to $0.52 on 2.3x average daily volume. Cardiome Pharma has traded 1.1 million shares thus far today, vs. average volume of 458,000 shares per day. The stock has outperformed the Dow (5.6% to the Dow's -0.8%) and outperformed the S&P 500 (5.6% to the S&P's -0.7%) during today's trading. In the past 52 weeks, Cardiome Pharma share prices have been bracketed by a low of $0.24 and a high of $2.69 and are now at $0.52, 117% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 4.5% while the 200-day MA has slid 0.9%. Potential upside of 25.6% exists for Cardiome Pharma, based on a current level of $0.52 and analysts' average consensus price target of $0.65. Cardiome Pharma shares have support at the 200-day moving average (MA) of $0.38 and additional support at the 50-day MA of $0.38. Cardiome Pharma Corp. is a product-focused cardiovascular drug development company with clinical drug programs. The Company's programs focus on atrial arrhythmia and congestive heart failure. SmarTrend recommended that subscribers consider buying shares of Cardiome Pharma on December 12th, 2012 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $0.41. Since that recommendation, shares of Cardiome Pharma have risen 21.7%. We continue to monitor CRME for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup |